| | Title | Authors / Editors | Date |
|
unige:135495 |
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. |
Brahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michael John; ... Hetland, Merete Lund |
2019 |
|
unige:135501 |
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration |
Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Askling, Johan; Ciurea, Adrian; ... Østergaard, Mikkel |
2019 |
|
unige:128225 |
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis |
Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem |
2019 |
|
unige:128226 |
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution |
Lauper, Kim; Mongin, Denis; Alpizar Rodriguez, Deshire; Codreanu, Catalin; ... Courvoisier, Delphine |
2019 |
|
unige:127635 |
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries |
Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Klami Kristianslund, Eirik; ... Gabay, Cem |
2018 |
|
unige:111916 |
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration |
Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem |
2018 |
Codreanu, Catalin
add all
remove all
